disodium 4-hydroxy-3-[[2-(hydroxy-oxido-phosphoryl)acetyl]amino]-4-oxo-butanoate

Suppliers

Names

[ CAS No. ]:
60342-56-5

[ Name ]:
disodium 4-hydroxy-3-[[2-(hydroxy-oxido-phosphoryl)acetyl]amino]-4-oxo-butanoate

[Synonym ]:
L-2-ammonio-4-oxobutanoate
(2S)-2-ammonio-4-oxobutanoate
N-phosphonoacetyl-L-aspartate de sodium
L-aspartate-4-semialdehyde
L-aspartate semialdehyde
N-(phosphonoacetyl)-,tetrasodium salt
aspartate semi-aldehyde

Chemical & Physical Properties

[ Molecular Formula ]:
C6H10NNaO8P+

[ Molecular Weight ]:
278.10900

[ Exact Mass ]:
278.00400

[ PSA ]:
171.04000

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CI9470000
CHEMICAL NAME :
L-Aspartic acid, N-(phosphonoacetyl)-, tetrasodium salt
CAS REGISTRY NUMBER :
60342-56-5
LAST UPDATED :
198803
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C6-H10-N-O8-P.4Na

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1763 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
530 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986

Precursor & DownStream

Precursor

DownStream

  • L-Aspartic acid

Related Compounds

  • 4-[3-(methoxymethyl)furan-2-yl]-1H-pyrazole
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 3-Amino-5-(propan-2-yl)-1,2-oxazole-4-sulfonyl fluoride
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • methyl 4-(azetidin-3-yl)-1-methyl-1H-pyrrole-2-carboxylate
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde